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Review Incremental value of contrast myocardial perfusion 
to detect intermediate versus severe coronary 
artery stenosis during stress-echocardiography
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Abstract
Background: We aimed to compare the incremental value of contrast myocardial perfusion imaging (MPI) for the 
detection of intermediate versus severe coronary artery stenosis during dipyridamole-atropine echocardiography 
(DASE).
Wall motion (WM) assessment during stress-echocardiography demonstrates suboptimal sensitivity to detect
coronary artery disease (CAD), particularly in patients with isolated intermediate (50%-70%) coronary stenosis.
Methods: We performed DASE with MPI in 150 patients with a suspected chest pain syndrome who were given clinical 
indication to coronary angiography.
Results and discussion: When CAD was defined as the presence of a ≥50% stenosis, the addition of MPI increased 
sensitivity (+30%) and decreased specificity (-14%), with a final increase in total diagnostic accuracy (+16%, p < 0.001). 
The addition of MPI data substantially increased the sensitivity to detect patients with isolated intermediate stenosis 
from 37% to 98% (p < 0.001); the incremental sensitivity was much lower in patients with severe stenosis, from 85% to 
96% (p < 0.05), at the expense of a higher decrease in specificity and a final decrease in total diagnostic accuracy (-18%, 
p < 0.001).
Conclusions: The addition of MPI on top of WM analysis during DASE increases the diagnostic sensitivity to detect 
obstructive CAD, whatever its definition (≥50% or > 70% stenosis), but it is mainly driven by the sensitivity increase in 
the intermediate group (50%-70% stenosis).
The total diagnostic accuracy increased only when defining CAD as ≥50% stenosis, since in patients with severe 
stenosis (> 70%) the decrease in specificity is not counterbalanced by the minor sensitivity increase.
Background
Standard pharmacological stress-echocardiography (SE)
has demonstrated suboptimal sensitivity to detect inter-
mediate coronary stenosis, particularly in patients with
single-vessel disease, not differently from other tech-
niques based on the detection of inducible wall motion
abnormalities [1-3]. Nonetheless the diagnosis of a coro-
nary stenosis between 50% and 70% in diameter is rele-
vant to the patient, since it may portend an unfavorable
prognosis when associated with reduced coronary flow
reserve or fractional flow reserve [2,4].
Both the quantitative measurement of myocardial
blood flow reserve and the more practical visual assess-
ment of myocardial perfusion (MPI) during contrast-SE
have demonstrated incremental sensitivity on top of wall
motion (WM) analysis to diagnose obstructive coronary
artery disease (CAD) [5-10].
The study hypothesis is that the potential incremental
diagnostic sensitivity and accuracy of MPI during dipyri-
damole-atropine echocardiography (DASE) is driven by
the higher sensitivity in the subset of patients with iso-
lated intermediate coronary stenosis. We performed
DASE with the addition of MPI in 150 consecutive
patients with a chest pain syndrome who were given clin-
ical indication to elective coronary angiography and we
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analyzed the diagnostic results based on the presence and
grade of coronary artery stenosis.
Methods
Patients
All patients who were clinically indicated elective coro-
nary angiography between March 2008 and January 2009
for a recent chest pain syndrome were asked their
informed consent to be enrolled in the study; the ones
who consented underwent DASE within 2 weeks before
coronary angiography, in the absence of the following
exclusion criteria:
Exclusion criteria
a) left ventricular ejection fraction (LVEF) < 30%, b)
severe valvular disease, c) sustained ventricular arrhyth-
mias or hemodynamic instability, d) insufficient acoustic
windows, e) known allergy to sulfonamides.
The study complied with the Declaration of Helsinki.
All patients gave written informed consent to the study
protocol, which was approved by the Institutional Review
Board of our Hospital.
Dipyridamole-atropine echocardiography
The contrast stress protocol is shown in Figure 1. All
images were acquired in the apical 4, 2 and 3 chamber
views using S5 broadband transducer (Philips, Eind-
hoven, Netherlands). Wall motion and myocardial perfu-
sion were assessed at rest and at peak stress. Sonovue
(Bracco, Milan, Italy) was infused using a rotating pump
(BR-NF100, Bracco, Geneva, Switzerland) at rest and 1
minute after completion of dipyridamole infusion. Low
power (0.10) continuous imaging was performed for WM
assessment. For MPI image acquisition a flash-replenish-
ment sequence (destructive pulse of 8 frames at a
mechanical index of 1.0, followed by low power imaging
for 10 cycles) was used both in the continuous (40
frames/sec) and triggered mode (end-systolic at every
cardiac cycle) [5].
Care was taken to opacify the left ventricle and the
myocardium homogeneously with minimization of atten-
uation so that it is confined to the atrium prior to acquisi-
tion of contrast imaging. To achieve this the infusion rate
and gain settings are adjusted (e.g. if the contrast attenua-
tion is seen in the LV cavity, infusion rate is reduced and
if the attenuation is optimal, then gains are increased for
optimal opacification). Gain settings are considered opti-
mal if the destructive impulses result in complete clear-
ance of microbubbles from the myocardium with very
little cavity contrast destruction.
Interpretation of WM and MPI
Contrast regional WM analysis was evaluated at baseline
and at peak stress by using a semi quantitative wall
motion score (normal, hypokinesia and akinesia) on a 17-
segment model of the left ventricle, according to the rec-
ommendations of the European Association of Echocar-
diography [11].
Abnormal WM was defined as the occurrence in at
least one segment of either a new dyssynergy in a region
with normal rest function or worsening of rest dyssyn-
ergy. Resting akinesia becoming dyskinesia or fixed WM
abnormalities were not considered a criterion for positiv-
ity.
Myocardial perfusion was considered as normal if the
myocardium was fully replenished 1.5-2 seconds after the
end of flash impulse at peak hyperemia and as abnormal
if the myocardium replenishment was delayed beyond 2
seconds. The cut-off for normal replenishment at rest
Figure 1 Stress echocardiography protocol. Abbreviations as in table 1.Gaibazzi et al. Cardiovascular Ultrasound 2010, 8:16
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was considered 4-5 seconds after the flash impulse. A
perfusion defect was scored as fixed or reversible based
on its presence or absence at rest. A reversible defect in
≥1 segment was defined as abnormal MPI.
Wall motion and MPI were analyzed separately at 2 dif-
ferent time points by consensus by 2 observers. Disagree-
ment was resolved by a third observer.
Quantitative Coronary Angiography
Quantitative coronary angiography (QCA) was per-
formed by a cardiologist (F.U.), unaware of the echocar-
diography results. Any evident stenosis was measured
(Qangio XA version 7.0, Medis, Leiden, the Netherlands)
and expressed as percent narrowing using the nearest
normal-appearing region as the reference. An intermedi-
ate stenosis was defined as luminal stenosis in one or
more coronary arteries or major branches between 50%
and 70%, while a severe stenosis was defined as > 70%
narrowing.
Patients were divided into subgroups: a) normal coro-
naries or < 50% stenosis, b) stenosis between 50% and
70% as the worst coronary lesion (INTERMEDIATE
group) or c) at least one > 70% stenosis (SEVERE group).
Patients with left main disease ≥50% were also included
in the SEVERE group. Multivessel disease was defined
when more than one of the three major coronary arteries
(or left main trunk) was affected by a ≥50% stenosis. Cor-
onary territories were assigned according to guidelines
[11].
Statistical analysis
Continuous variables were presented as mean and stan-
dard deviation and were compared using the Student t
test. Categorical variables were examined with a chi-
square test when appropriate (expected frequency > 5),
otherwise a Fisher exact test was used. Sensitivity, speci-
ficity and accuracy were calculated using standard defini-
tions and were presented with 95% confidence intervals
(CI). Differences between sensitivity, specificity and accu-
racy using WM or WM+MPI were analyzed using McNe-
mar's test. A value of p < 0.05 (2 sided) was considered
significant. Interobserver and intraobserver agreement
was determined for both WM and MPI in 30 randomly
selected patients. Results were presented as a percentage
with a corresponding kappa value. Statistical analysis was
performed with SPSS version 15.0 (SPSS Inc, Chicago,
Ill).
Results
Clinical data
169 consecutive patients met the inclusion criteria; 11
denied informed consent and 8 met exclusion criteria (6
insufficiently echogenic and 2 reporting known allergy to
sulfonamides). 150 patients were finally enrolled. Mean
age was 70 ± 9, 78 (52%) were males, 115 (77%) had at
least 2 traditional risk factors for CAD, 40 (27%) had dia-
betes mellitus and 51 (34%) had a previous myocardial
infarction or percutaneous coronary intervention; 47
subjects (31%) had a final angiographic result of single
vessel-disease, 55 (37%) multivessel, while 48 (32%) had
normal or < 50% stenosed coronary arteries. All demo-
graphic and clinical data were comparable between the
INTERMEDIATE and the SEVERE group.
Stress echocardiography
The prevalence of reversible WM abnormalities was
higher in the SEVERE group when compared with the
INTERMEDIATE group (p < 0.001); in contrast, the
prevalence of MPI abnormalities was not different
between the two groups (Table 1).
Sensitivity, specificity and accuracy for WM and
WM+MPI in patients with any stenosis ≥ 50% (INTER-
MEDIATE+SEVERE groups) or > 70% only (SEVERE
group) are reported in Figure 2, along with sensitivity
data for the INTERMEDIATE group.
Sensitivity using WM+MPI resulted significantly
higher than using WM data only, whatever the cut-off
used to define CAD. The sensitivity increase was highest
in the INTERMEDIATE group, from 37% (CI 25%-47%)
to 98% (CI 89%-100%), (p < 0.001).
The sensitivity increase of WM+MPI for CAD ≥50%,
from 66% (CI 61%-70%) to 96% (CI 92%-99%) (p < 0.001),
was only partially counterbalanced by the specificity
decrease from 83% (CI 70%-92%) to 69% (CI 61%-74%) (p
< 0.05); MPI total accuracy resulted higher compared
with standalone WM analysis, 87% (CI 82%-93) vs 71%
(CI 65%-78%), (p < 0.001). On the contrary, in the
SEVERE group the decrease in specificity obtained with
the addition of MPI data was much higher, from 74% (CI
67%-79%) to 38% (CI 29%-49%, p < 0.001), than the sensi-
tivity increase, from 85% (CI 76%-91%) to 96% (CI 92%-
99%), p < 0.05), with final lower total accuracy, from 79%
(CI 72%-83%) to 61% (54-65) (p < 0.001).
The addition of MPI identified 25 more true positive
patients than WM in the INTERMEDIATE group; among
them, in 13 patients (52%) the intermediate stenosis
detected was in the anterior circulation (anterior
descending coronary artery), in 10 patients (40%) in the
posterior circulation (right or circumflex coronary
artery) and in 2 patients (8%) both in the anterior and
posterior circulation.
The addition of MPI identified 6 more true positive
patients than WM in the SEVERE group, 5 with stenosis
both in the anterior and posterior circulation (multivessel
disease) and 1 with a single stenosis in the anterior circu-
lation (single-vessel disease).
Figure 3 shows the average stenosis diameter in patients
who underwent QCA, classified into three subgroupsGaibazzi et al. Cardiovascular Ultrasound 2010, 8:16
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based on SE results: MPI-/WM-, MPI+/WM-, MPI+/
WM+.
Figure 4 shows a typical DASE examination resulting
positive for MPI after dipyridamole with normal peak
WM, in a patient finally diagnosed with two-vessel 50%-
70% coronary artery stenosis (see also Additional File 1).
Intra/interobserver variability
The intraobserver agreement on the presence or absence
of reversible visual MPI or WM abnormality after dipyri-
damole is respectively 97% (Kappa = 0.91) and 100%
(Kappa = 1); the interobserver agreement data is respec-
tively 93% (Kappa = 0.83) and 90% (Kappa = 0.73).
Feasibility and Safety
The test could be performed and interpreted both for
WM and MPI in all enrolled patients, after the initial
exclusion of 8 patients for poor acoustic windows or sul-
fonamide allergy. Feasibility of DASE was consequently
95%.
After dipyridamole infusion mild flushing or headache
were commonly reported. There were no serious or irre-
versible adverse events. There was no suggestion for any
direct adverse effect related to contrast infusion.
Discussion
Potential clinical value of detecting intermediate stenosis
An intermediate stenosis has a negative prognostic
impact on future cardiac events only if associated with a
reduced coronary (CFR) or fractional flow reserve (FFR);
CFR or FFR have been found reduced in more than half of
patients with known intermediate stenosis, non-inva-
sively studied using stress-echocardiography (CFR
assessment), or invasively studied with Doppler flow-wire
measurements (FFR assessment) [2,4]. The detection of
a n in t e rm edia t e  s t e nosis m a y c o nseque n t ly be  r e l eva n t
for the clinical prognosis of patients, although the man-
agement of such intermediate stenosis needs to be tai-
lored on a single patient basis.
Table 1: Clinical characteristics and echocardiographic data in the 3 angiographic categories, according to QCA results.
Study group n = 150 No CAD CAD 50%-70% CAD > 70% p value
Patients n (%*) 48 41 61 -
Age, mean(± 1 SD), y 64 (10) 69 (9) 70 (9) ns
Men, n (%) 26 (54) 24 (59) 40 (65) ns
Risk factors ≥2, n (%) 37 (77) 34 (85) 51 (84) ns
Hypertension, n (%) 32 (67) 30 (73) 42 (69) ns
Diabetes Mellitus n (%) 6 (13) 12 (29) 19 (31) ns
Prior myocardial infarction or PCI n (%) 11 (23) 13 (32) 23 (38) ns
Presence of baseline WM abnormalities, n % 10 (21) 14 (34) 24 (39) ns
Baseline LVEF, % 57 ± 8 54 ± 9 52 ± 10 ns
Abnormal WM, n (%) 8 (17) 15 (37) 52 (85) p < 0.001
Abnormal myocardial perfusion n (%) 15 (31) 40 (98) 58 (95) ns
Peak RPP mean(± 1 SD) 15124 (3140) 15416(3684) 14615(2705) ns
Risk factors considered were: hypertension, diabetes, current smoking, hypercholesterolemia, familiar history of premature coronary artery 
disease (CAD) and obesity. The "No CAD" group includes patients with < 50% CAD. P value refers to difference between the 2 disease groups 
"CAD 50%-70%" and "CAD > 70%". QCA = quantitative coronary angiography, PCI = percutaneous coronary intervention, LVEF = left 
ventricular ejection fraction, WM = wall motion, MPI = myocardial perfusion imaging, RPP = rate-pressure productGaibazzi et al. Cardiovascular Ultrasound 2010, 8:16
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The long-term prognostic value of MPI for hard cardiac
events, independently by WM, has been clearly demon-
strated [12,13], however no single study specifically
addressed the prognostic value of a MPI defect subtended
by an intermediate stenosis.
In conclusion, whether a reversible perfusion defect in
patients with isolated intermediate stenosis implies an
unfavorable prognosis is a question that remains unan-
swered.
Wall motion criteria in intermediate stenosis
Contemporary studies using either dipyridamole or dob-
utamine echocardiography clearly demonstrated the sub-
optimal sensitivity of pharmacologic stress protocols to
detect intermediate stenosis when using standard WM
criteria [1,2,14,15]. In a study using MPI in conjunction
with dobutamine-atropine SE, pooled sensitivity of WM
criteria for intermediate stenosis was only 30%, increas-
ing to 67% when MPI was added [1].
A recent study, in which high dose dipyridamole was
used, reported a 20% sensitivity for WM criteria to detect
50%-75% coronary stenosis in patients with isolated
intermediate stenosis of the anterior descending coronary
artery; transthoracic Doppler CFR in this study was very
effective to overcome the limited sensitivity of WM, but
in the clinical practice the undisputable value of non-
invasive CFR measurement is technically limited to the
anterior coronary circulation [2].
The incremental value of contrast MPI is instead main-
tained for all coronary territories, as previously reported
[1]. In our study the anterior circulation was affected in
only 60% of patients with isolated intermediate stenosis.
Another study demonstrated a major step-up in sensi-
tivity for detection of an intermediate stenosis (associated
with fractional flow reserve < 0.75) by the use of contrast
for left ventricle opacification during dobutamine
echocardiography; in this case sensitivity increased from
48% for standard echocardiography without contrast, to
83% with the use of contrast for opacification, reflecting
the usefulness of better endocardial border delineation
[15].
Sensitivity data in this study, which is otherwise partic-
ularly interesting for the choice of a hemodynamic func-
tional endpoint, are presumably much higher than real
because of the bias of performing and interpreting the
tests in patients with previously known intermediate
stenosis, which was the reason for stress-testing.
Clinical value of contrast MPI, costs and safety issues
Contrast use to date is not approved specifically for MPI
by the European Medicines Agency (EMEA) and its use
remains consequently investigational. In our study con-
trast MPI is useful to increase the sensitivity of pharma-
Figure 2 Sensitivity, specificity and accuracy for each subgroup. Accuracy data with corresponding 95% confidence intervals for wall motion and 
wall motion+myocardial perfusion imaging to detect patients with coronary artery stenosis between 50% and 70%, ≥ 50%, or > 70%. In the interme-
diate (50%-70% stenosis) group only sensitivity can be calculated, since in this case patients with a > 70% stenosis cannot be classified, although key 
to specificity and accuracy measurement. In the CAD > 70% an abnormal test with angiographic 50%-70% stenosis is considered a false positive. * p 
< 0.001, † p < 0.05 compared to wall motion criteria.Gaibazzi et al. Cardiovascular Ultrasound 2010, 8:16
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cologic stress-echocardiography when the diagnosis of
less severe CAD/stenosis is the diagnostic endpoint,
while for more severe CAD/stenosis the profound loss in
specificity leads to a significant loss in accuracy, com-
pared with standard WM analysis; whether the diagnostic
cost-benefit profile of adding contrast MPI is worth the
potential safety issues and contrast-related costs is still a
matter of discussion. An isolated MPI abnormality (ie,
with normal WM) should not be used as the sole indica-
tion to coronary angiography, due to its low specificity for
epicardial obstructive CAD.
Figure 3 Average stenosis diameter. Average stenosis diameter in patients who underwent QCA, classified into three subgroups based on SE re-
sults: MPI-/WM-, MPI+/WM-, MPI+/WM+. Abbreviations as defined in table 1.
Figure 4 Flash replenishment sequence. Assessment of myocardial perfusion after dipyridamole. From left to right: uniform transmural perfusion 
seen in apical 4-chamber before flash, then images taken 1, 3, 4 and 8 cardiac cycles after microbubbles destruction. Perfusion defects become ap-
parent after flashing (flash icon in the figure) both in the anterior descending and circumflex coronary arteries perfusion territories, still detectable after 
8 cycles; the patient had no clear WM abnormality, even if mild tardokinesia of the septum was suspected. Angiography confirmed obstructive two-
vessel disease with both stenosis ranging between 50% and 70%. Abbreviations as defined in table 1.Gaibazzi et al. Cardiovascular Ultrasound 2010, 8:16
http://www.cardiovascularultrasound.com/content/8/1/16
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False positives and coronary angiography
Patients with a positive provocative test (whatever stress-
test considered) and no obstructive epicardial CAD at
coronary angiography are usually defined as false-posi-
tives. It is now widely recognized that in many different
clinical situations (microvascular disease, diffused coro-
nary atherosclerosis, subcritical disease with coronary
remodeling, myocardial bridges, coronary spasm, cardio-
myopathies and others) coronary blood flow under stress
condition may be significantly reduced in the absence of
epicardial > 50% stenosis, up to the level capable to cause
chest pain, ECG and perfusion abnormalities and, less
frequently, WM abnormalities [16]. MPI is intrinsically
incline to a higher "false positivity" rate than WM, due to
its earlier role in the pathophysiology of the ischemic cas-
cade.
Few stress-echocardiography studies reported that
patients with so called "normal coronaries" and an abnor-
mal stress-test (for WM or CFR-LAD) have a worse car-
diac prognosis than patients with a normal test [17,18].
Limitations
The specificity of WM in our study was lower than
reported by several previous studies; this may be due to
the non-conservative reading criteria adopted (≥1 seg-
ment with new dyssynergy in a region with normal rest
function or worsening of rest dyssynergy), that were any-
way similarly applied to MPI (≥1 segment with reversible
MPI defect). Analysis of echocardiographic data was per-
formed on a patient-basis and not on a territory-basis,
since we felt it inappropriate, stress-echocardiograms
being always interrupted in our centre at the very first
sign of positivity, for safety reasons. The limitations of
angiographic comparisons in relation to the discrepancy
between stenosis severity and functional significance are
pertinent to our study too. Use of angiographic data alone
ignores patients with non-ischemic cardiomyopathies,
the previous occurrence of coronary events in patients
without significant stenosis or microcirculation disease.
Wall motion abnormalities or MPI defects in these
patients are classified as false-positives; in our experience
this has a major impact on MPI data, more than on WM
data.
Conclusion
The current study shows that most of the incremental
diagnostic sensitivity of MPI over WM analysis during
D A S E  o r i g i n a t e s  f r o m  p a t i e n t s  w i t h  c o r o n a r y  a r t e r y
stenosis of intermediate severity, defined as 50%-70% in
luminal diameter. Interestingly, MPI maintains incremen-
tal sensitivity in the SEVERE group also, but clinically less
significant. In the SEVERE group, however, the addition
of MPI decreased the specificity more than how it
increased the sensitivity, resulting in lower total accuracy,
compared with WM assessment. The opposite is true
when targeting coronary artery stenosis ≥50%.
We conclude that MPI should be used with caution if
the endpoint of the test is the identification of angio-
graphically severe (> 70%, so called "critical") stenosis. In
this case the trade-off of MPI between sensitivity and
specificity becomes unfavorable for MPI, while stand-
alone WM assessment (using left ventricle contrast
opacification, as we did in our study) maintains a higher
total accuracy.
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